Powerlifters IGF-1 LR3 Protocol — Dosing and Timing
IGF-1 LR3 for powerlifters requires 20–80mcg daily dosing, split timing around training, and 4–6 week cycles to avoid receptor desensitization and
Category: Blog
Your blog category
Marathon Runners Researching BPC-157 — Recovery Science
BPC-157 reduces inflammatory markers by 30–40% in tendon studies, but human marathon data remains limited. Research-backed protocol guidance for endurance
Marathon Runners BPC-157 Protocol — Dosing & Recovery
Marathon runners use BPC-157 at 250–500mcg daily subcutaneously for 4–6 weeks targeting tendon repair, inflammation reduction, and accelerated tissue
TB-500 for Marathon Runners — Recovery Peptide Explained
TB-500 accelerates soft tissue repair by upregulating actin, cutting recovery time between high-mileage training blocks. Here’s what marathon runners need
Marathon Runners TB-500 Protocol — Recovery & Dosing Guide
Marathon runners TB-500 protocol delivers tendon repair and inflammation control. Learn exact dosing, injection timing, and recovery timelines backed by
Marathon Runners Researching TB-500 — Recovery Science
TB-500 accelerates soft tissue repair through upregulation of actin-binding proteins — marathon runners use it for tendon inflammation and accelerated
Best Peptides for Cyclists — Performance & Recovery
The best peptides for cyclists target oxygen delivery, mitochondrial efficiency, and tendon repair — BPC-157, TB-500, and MOTS-C lead clinical research
MOTS-c for Cyclists — Performance and Recovery Benefits
MOTS-c activates AMPK to enhance mitochondrial efficiency, improve VO2 max, and accelerate recovery — this guide covers dosing, timing, and real-world
Cyclists MOTS-C Protocol — Performance & Recovery Benefits
MOTS-C activates AMPK to enhance mitochondrial function, VO₂ max, and lactate clearance — the protocol cyclists use for sustained endurance and faster
BPC-157 for Cyclists — Recovery Science Explained
BPC-157 accelerates tendon healing through Type I collagen synthesis and VEGF upregulation — research shows 60–70% faster recovery in animal models of
